194 related articles for article (PubMed ID: 12234095)
21. Characterization of an oxygen/redox-dependent degradation domain of hypoxia-inducible factor alpha (HIF-alpha) proteins.
Srinivas V; Zhang LP; Zhu XH; Caro J
Biochem Biophys Res Commun; 1999 Jul; 260(2):557-61. PubMed ID: 10403805
[TBL] [Abstract][Full Text] [Related]
22. Identification of a novel growth factor-responsive gene in vascular smooth muscle cells.
Wax SD; Rosenfield CL; Taubman MB
J Biol Chem; 1994 Apr; 269(17):13041-7. PubMed ID: 8175725
[TBL] [Abstract][Full Text] [Related]
23. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway.
Huang LE; Gu J; Schau M; Bunn HF
Proc Natl Acad Sci U S A; 1998 Jul; 95(14):7987-92. PubMed ID: 9653127
[TBL] [Abstract][Full Text] [Related]
24. Binding and regulation of HIF-1alpha by a subunit of the proteasome complex, PSMA7.
Cho S; Choi YJ; Kim JM; Jeong ST; Kim JH; Kim SH; Ryu SE
FEBS Lett; 2001 Jun; 498(1):62-6. PubMed ID: 11389899
[TBL] [Abstract][Full Text] [Related]
25. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia.
Berra E; Benizri E; Ginouvès A; Volmat V; Roux D; Pouysségur J
EMBO J; 2003 Aug; 22(16):4082-90. PubMed ID: 12912907
[TBL] [Abstract][Full Text] [Related]
26. Expression of prolyl hydroxylase domains, the upstream regulators of HIF, in the brain of the anoxia-tolerant crucian carp during anoxia-reoxygenation.
Gerber L; Resseguier J; Helle-Valle T; Farhat E; Nilsson GE; Lefevre S
Am J Physiol Regul Integr Comp Physiol; 2024 Feb; 326(2):R184-R195. PubMed ID: 38145292
[TBL] [Abstract][Full Text] [Related]
27. Activation of hypoxia-induced transcription in normoxia.
Hägg M; Wennström S
Exp Cell Res; 2005 May; 306(1):180-91. PubMed ID: 15878343
[TBL] [Abstract][Full Text] [Related]
28. SM-20 is a novel growth factor-responsive gene regulated during skeletal muscle development and differentiation.
Moschella MC; Menzies K; Tsao L; Lieb MA; Kohtz JD; Kohtz DS; Taubman MB
Gene Expr; 1999; 8(1):59-66. PubMed ID: 10543731
[TBL] [Abstract][Full Text] [Related]
29. A conserved family of prolyl-4-hydroxylases that modify HIF.
Bruick RK; McKnight SL
Science; 2001 Nov; 294(5545):1337-40. PubMed ID: 11598268
[TBL] [Abstract][Full Text] [Related]
30. Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system.
Takeda K; Cowan A; Fong GH
Circulation; 2007 Aug; 116(7):774-81. PubMed ID: 17646578
[TBL] [Abstract][Full Text] [Related]
31. Regulation of the SM-20 prolyl hydroxylase gene in smooth muscle cells.
Menzies K; Liu B; Kim WJ; Moschella MC; Taubman MB
Biochem Biophys Res Commun; 2004 May; 317(3):801-10. PubMed ID: 15081411
[TBL] [Abstract][Full Text] [Related]
32. Prolyl hydroxylation by EglN2 destabilizes FOXO3a by blocking its interaction with the USP9x deubiquitinase.
Zheng X; Zhai B; Koivunen P; Shin SJ; Lu G; Liu J; Geisen C; Chakraborty AA; Moslehi JJ; Smalley DM; Wei X; Chen X; Chen Z; Beres JM; Zhang J; Tsao JL; Brenner MC; Zhang Y; Fan C; DePinho RA; Paik J; Gygi SP; Kaelin WG; Zhang Q
Genes Dev; 2014 Jul; 28(13):1429-44. PubMed ID: 24990963
[TBL] [Abstract][Full Text] [Related]
33. Signal transduction. How do cells sense oxygen?
Zhu H; Bunn HF
Science; 2001 Apr; 292(5516):449-51. PubMed ID: 11292863
[TBL] [Abstract][Full Text] [Related]
34. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.
Maxwell PH; Wiesener MS; Chang GW; Clifford SC; Vaux EC; Cockman ME; Wykoff CC; Pugh CW; Maher ER; Ratcliffe PJ
Nature; 1999 May; 399(6733):271-5. PubMed ID: 10353251
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein.
Tanimoto K; Makino Y; Pereira T; Poellinger L
EMBO J; 2000 Aug; 19(16):4298-309. PubMed ID: 10944113
[TBL] [Abstract][Full Text] [Related]
36. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.
Jokilehto T; Rantanen K; Luukkaa M; Heikkinen P; Grenman R; Minn H; Kronqvist P; Jaakkola PM
Clin Cancer Res; 2006 Feb; 12(4):1080-7. PubMed ID: 16489060
[TBL] [Abstract][Full Text] [Related]
37. Somatic pairing of chromosome 19 in renal oncocytoma is associated with deregulated EGLN2-mediated [corrected] oxygen-sensing response.
Koeman JM; Russell RC; Tan MH; Petillo D; Westphal M; Koelzer K; Metcalf JL; Zhang Z; Matsuda D; Dykema KJ; Houseman HL; Kort EJ; Furge LL; Kahnoski RJ; Richard S; Vieillefond A; Swiatek PJ; Teh BT; Ohh M; Furge KA
PLoS Genet; 2008 Sep; 4(9):e1000176. PubMed ID: 18773095
[TBL] [Abstract][Full Text] [Related]
38. Evolution, characterization, and expression profile of Egl-9 family hypoxia-inducible factor (
Ma F; Zou Y; Chen X; Ma L; Ma R
Anim Biotechnol; 2023 Nov; 34(5):1753-1762. PubMed ID: 35289728
[TBL] [Abstract][Full Text] [Related]
39. Tumor suppressor SPOP ubiquitinates and degrades EglN2 to compromise growth of prostate cancer cells.
Zhang L; Peng S; Dai X; Gan W; Nie X; Wei W; Hu G; Guo J
Cancer Lett; 2017 Apr; 390():11-20. PubMed ID: 28089830
[TBL] [Abstract][Full Text] [Related]
40. Control of cyclin D1 and breast tumorigenesis by the EglN2 prolyl hydroxylase.
Zhang Q; Gu J; Li L; Liu J; Luo B; Cheung HW; Boehm JS; Ni M; Geisen C; Root DE; Polyak K; Brown M; Richardson AL; Hahn WC; Kaelin WG; Bommi-Reddy A
Cancer Cell; 2009 Nov; 16(5):413-24. PubMed ID: 19878873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
